These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25106704)

  • 1. Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes.
    Bianchi A; Moulin D; Hupont S; Koufany M; Netter P; Reboul P; Jouzeau JY
    Free Radic Biol Med; 2014 Nov; 76():114-26. PubMed ID: 25106704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
    Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
    Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells.
    Moulin D; Poleni PE; Kirchmeyer M; Sebillaud S; Koufany M; Netter P; Terlain B; Bianchi A; Jouzeau JY
    Biorheology; 2006; 43(3,4):561-75. PubMed ID: 16912428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
    Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
    Zhao X; Zhang Y; Strong R; Grotta JC; Aronowski J
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):811-20. PubMed ID: 16208315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.
    Kaplan JM; Cook JA; Hake PW; O'Connor M; Burroughs TJ; Zingarelli B
    Shock; 2005 Jul; 24(1):59-65. PubMed ID: 15988322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.